Trial Profile

A phase 1b study for GEM-AKI for the prevention and treatment of AKI due to cardiac surgery

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 16 Aug 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

09 Aug 2024 According to a Revelation Biosciences media release, during the second half of 2024, company look forward to building on this momentum with the start of a Phase 1b study in CKD patients.
24 Jun 2024 According to a Revelation Biosciences media release, results from another phase 1 trial and maximum tolerated dose will be used to guide dose level selection in a planned randomized, placebo-controlled Phase 1b study in patients with chronic kidney disease in late 2024.
06 Feb 2024 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com